The need for a population-based, dose optimization study for recombinant tissue plasminogen activator in acute ischemic stroke: A study from a tertiary care teaching hospital from South India
- Siju Abraham*
- , Fazil Thaha
- , S. Krishnan
- , Athulya Shajan
- , Jayaraj Balakrishnan
- , Babu Palatty
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
2
Link opens in a new tab
Citations
(Scopus)